Table 4.

Eye Bank Association of America (EBAA) Guidelines for Evaluation of Viable Donors⁶⁸

Criteria	Recommendations for Corneal Viability of Donors with Potential COVID-19 Infection
PCR Test	RT-PCR test must be performed either 24 hours after death or within 28 days prior to death. Donors should be excluded if the test is inconclusive.
Signs	If donor contracted any of the following signs within 28 days prior to death, donor cornea is not viable. The signs include: (1) Acute respiratory distress syndrome (ARDS) (2) Pneumonia (3) Detection of “ground glass opacities” via pulmonary computed tomography (PCT)
Symptoms	If donor had various symptoms consistent with criteria below within 28 days prior to death, donor cornea is not viable. One from the below: (1) Fever or chills (2) Difficulty breathing or shortness of breath (3) Coughing (4) Loss of taste or smell OR two from the below: (1) Headache (2) Sore Throat (3) Congestion (4) Nausea (5) Fatigue (6) Muscle Aches
Contact	Donor being within six feet of a COVID-19 case or in direct contact with secretions from COVID-case
Vaccination	At the time of death, donor would be considered as fully vaccinated under two conditions: (1) 2 weeks have passed since donor’s second dose in a 2-dose series such as the Pfizer or Moderna vaccines. (2) 2 weeks have passed after a single-dose vaccine such as Johnson & Johnson’s Janssen vaccine

Note: Data from Eye Bank Association of America (EBAA) (URL: https://restoresight.org/covid-19-updates/).⁶⁸